Atypical MRI Findings in Canavan Disease: A Patient with a Mild Course

Abstract

Canavan disease is a severe, progressive leukodystrophy with an autosomal recessive inheritance, caused by aspartoacylase (ASPA) deficiency. The characteristic MRI features include diffuse, symmetrical white matter degeneration in the subcortical areas, with bilateral involvement of the globus pallidus. Proton magnetic resonance spectroscopy of the brain shows an increase in the concentration of N-acetylaspartic acid (NAA). The altered NAA metabolism has been traced to mutations in the gene encoding ASPA, located on chromosome 17 (17p13-ter). We present here a patient with a mild form of Canavan disease confirmed with the absent ASPA activity, atypical MRI findings, related to compound heterozygosity for a missense mutation, p.Tyr288Cys, and the known pan-European mutation, the p.Ala305Glu.

Key words

Canavan disease - MRI - mild course - mutations

References

• 1 Baslow M H. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.  J Mol Neurosci. 2000;  15 61-69
• 2 Brismar J, Brismar G, Gascon G, Ozand P. Canavan disease: CT and MR imaging of the brain.  AJNR. 1990;  11 805-810
• 3 Canavan M. Schilder's encephalitis periaxialis diffusa: Report of a child aged sixteen and one half months.  Arch Neurol Psychiatr. 1931;  25 299-308
• 4 Elpeleg O N, Shaag A. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.  J Inherit Metab Dis. 1999;  22 531-534
• 5 Kaul R, Gao G P, Balamurugan K, Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease.  Nat Genet. 1993;  5 118-123
• 6 Kaul R, Gao G P, Michals K, Whelan D T, Levin S, Matalon R. Novel (cys152 > arg) missense mutation in an Arab patient with Canavan disease.  Hum Mutat. 1995;  5 269-271
• 7 Kronn D, Oddoux C, Phillips J, Ostrer H. Prevalence of Canavan disease heterozygotes in the New York metropolitan Ashkenazi Jewish population [letter].  Am J Hum Genet. 1998;  57 1250-1252
• 8 Matalon R, Kaul R, Michals K. Carrier rate of Canavan disease among Ashkenazi Jewish individuals.  Am J Hum Genet. 1994;  55 157
• 9 Matalon R, Michals-Matalon K. Molecular basis of Canavan disease.  Eur J Paediatr Neurol. 1998;  2 69-76
• 10 Matalon R, Michals-Matalon K. Recent advances in Canavan disease.  Adv Pediatr. 1999;  46 493-506
• 11 Matalon R, Michals K, Sebatsa D, Deaching M, Gashkoff P, Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease.  Am J Med Genet. 1988;  29 463-471
• 12 Shaag A, Anikster Y, Christensen E, Glustein J Z, Fois A, Michelakakis H. et al . The molecular basis of Canavan (aspartoacylase deficiency) disease in European non-Jewish patients.  Am J Hum Genet. 1995;  57 572-580
• 13 Surendran S, Bamforth F J, Chan A, Tyring S K, Goodman S I, Matalon R. Mild elevation of N-acetylaspartic acid and macrocephaly: A diagnostic problem.  J Child Neurol. 2003;  18 809-812
• 14 Surendran S, Michals-Matalon K, Quast M J, Tyring S K, Wei J, Ezel E L. et al . Canavan disease: a monogenic trait with complex genomic interaction.  Mol Gen Met. 2003;  80 74-80
• 15 Toft P B, Geiss-Holtorff R, Rolland M O, Pryds O, Muller-Forell W, Christensen E. et al . Magnetic resonance imaging in juvenile Canavan disease.  Eur J Pediatr. 1993;  152 750-753
• 16 van Bogaert L, Bertrand I. Sur une idiotie familiale avec dégénérescence spongieuse du névraxe.  Acta Neur Psychiatr Belg. 1949;  49 572-585
• 17 van der Knaap, Walk J. Magnetic Resonance of Myelin, Myelination, and Myelin Disorders: Canavan Disease. 2nd ed. Heidelberg, Berlin; Springer 1995: 216-219
• 18 Zafeiriou D I, Kleijer W J, Maroupoulos G, Anastasiou A L, Augoustidou-Savvopoulou P, Papadopoulou F. et al . Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings.  Brain Dev. 1999;  21 205-208
• 19 Zelnik N, Luder A S, Elpeleg O N, Gross-Tsur V, Amir N, Hemli J A. et al . Protracted clinical course for patients with Canavan disease.  Dev Med Child Neurol. 1993;  35 355-358
• 20 Zeng B J, Wang Z H, Ribeiro L A, Leone P, De Gasperi R, Kim S J. et al . Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.  J Inherit Metab Dis. 2002;  25 557-570